Navigation Links
PharmaPoint: Alzheimer’s Disease - UK Drug Forecast and Market Analysis to 2022
Date:10/24/2013

Namenda 60
Table 12:Namenda SWOT Analysis, 2013 62
Table 13:Overall Unmet Needs - Current Level of Attainment 64
Table 14:Clinical Unmet Needs - Gap Analysis, 2013 71
Table 15:Technology Trends Analytic Framework for the AD Pipeline, 2012 81
Table 16:Comparison of Therapeutic Classes in Development for AD, 2013 81
Table 17:Comparison of Therapeutic Classes in Development for AD, 2013 82
Table 18:Product Profile - Arimenda 83
Table 19:Arimenda SWOT Analysis, 2013 85
Table 20:Product Profile - Solanezumab 86
Table 21:Solanezumab SWOT Analysis, 2013 89
Table 22:Product Profile - Gantenerumab 90
Table 23:Gantenerumab SWOT Analysis, 2013 94
Table 24:Product Profile - Crenezumab 95
Table 25:Crenezumab SWOT Analysis, 2013 97
Table 26:Product Profile - TRx0237 98
Table 27:TRx0237 SWOT Analysis, 2013 100
Table 28:Product Profile - MK-8931 101
Table 29:MK-8931 SWOT Analysis, 2013 104
Table 30:Product Profile - EVP-6124 105
Table 31:EVP-6124 SWOT Analysis, 2013 107
Table 32:Product Profile - Lu AE58054 108
Table 33:Lu AE58054 SWOT Analysis, 2013 110
Table 34:Sales Forecasts ($m) for AD in the United Kingdom, 2012-2022 112
Table 35:Key Events Impacting Sales for AD in the United Kingdom, 2012-2022 114
Table 36:AD Market in the United Kingdom - Drivers and Barriers, 2012-2022 114
Table 37:Key Launch Dates 137
Table 38:Key Patent Expirations 138

List of Figures

Figure 1:Atrophy of the Brain in AD 20
Figure 2:Key Pathological Features in AD Versus a Healthy Neuron 22
Figure 3:Non-Amyloidogenic Metabolism of APP 24
Figure 4:Amyloidogenic Metabolism of APP 25
Figure 5:Neurofibrillary Tangles 27
Figure 6:Oxidative Damage Due to Free Radicals 29
Figure 7:Strategic Competitor Assessment of the Marketed Products in AD, 2013 45
Figure 8:A
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. PharmaPoint: Chronic Heart Failure - US Drug Forecast and Market Analysis to 2022
2. PharmaPoint: Alzheimer’s Disease - US Drug Forecast and Market Analysis to 2022
3. PharmaPoint: Chronic Myeloid Leukemia (CML) - United Kingdom Drug Forecast and Market Analysis to 2022
4. PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - Current and Future Players
5. PharmaPoint: Chronic Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to 2022
6. PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - US Drug Forecast and Market Analysis to 2022
7. Changes in Epigenetic DNA Functions Reveal How Diabetes Predisposes Individuals to Alzheimer’s Disease
8. Diamond Fitness to Host Senior Dinner Dance to Raise Money for the Alzheimer’s Association
9. Eldercare Expert Judie Rappaport Releases New Report on the Rising Impact of Alzheimer’s Disease on the American Family
10. Feinstein Institute Researcher Organizes LI Alzheimer’s Consortium
11. Alzheimer’s Disease: Landmark Gene Discoveries Open Up New Therapeutic Opportunities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
(Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
(Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
(Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
(Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
... frozen plasma are being used inappropriately, states a commentary ... ) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj081933.pdf . There ... of red blood cells and platelets but not enough ... "Two recent studies in Canada found that 45% ...
... ... the counter medical products has signed a 6 year deal with international super bantam weight ... in the Philippines , ... -- The company’s flagship product, a lotion called Elmore Oil ( www.elmoreoil.com.au ), ...
... informed PharmaMar SA (Grupo Zeltia, ZEL.MC) that the regulatory authorities in Israel , ... in adults. Furthermore, the authorities in Paraguay and Azerbaijan have approved ... Paraguay and Azerbaijan . , ... ...
... ST. PAUL (March 15, 2010) Researchers at the University ... may, over the long term, protect the hearts of ... common form of muscular dystrophy in children. The chemical, ... seeks out tiny cuts in diseased heart muscle. When ...
... , MISSISSAUGA, ON , March 15 /PRNewswire-FirstCall/ ... company focused on the research and development of drug products ... topical and transdermal drug delivery technologies, and on the development ... it has enrolled the first patient in its European Phase ...
... of Dermatology, researchers report that in the United States, melanoma ... in the population 65 years and older. The incidence of ... have the highest rate of mortality. Epidemiologists say that one in ... lifetime, in contrast to one in 1,500 persons in the 1930s. ...
Cached Medicine News:Health News:Filipino World Champion Endorses Charity to Help Fight Child Poverty 2Health News:Filipino World Champion Endorses Charity to Help Fight Child Poverty 3Health News:Yondelis(R) Receives Five New Approvals Outside the European Economic Area 2Health News:Yondelis(R) Receives Five New Approvals Outside the European Economic Area 3Health News:Yondelis(R) Receives Five New Approvals Outside the European Economic Area 4Health News:Researchers discover chemical that may protect hearts of muscular dystrophy patients 2Health News:Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial 2Health News:Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial 3Health News:Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial 4Health News:Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial 5Health News:Late-stage melanoma results in economic burden 2
(Date:1/15/2014)... , Jan. 15, 2014  Research and Markets ... the "Dental Consumables Market - Global Industry ... - 2018" report to their offering. ... ) Dental consumables are products which are ... impairments, for tooth restoration and in treatment of ...
(Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading ... company, awarded several new IT value-added reseller (VAR) ... hospital organizations with IT goods and services at ... agreements, as well as value-added services such as ... New Novation agreements were awarded to ...
(Date:1/15/2014)... DUBLIN , January 15, 2014 ... that it has waived the Office of Fair Trading (OFT) ... the outstanding shares of ViroPharma Incorporated (NASDAQ: VPHM).   ... no longer conditional on OFT approval, and Shire expects to ... currently scheduled expiration time, subject to the satisfaction of all ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
... To Be Presented at American Association of Immunologists ... 2008 ,Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) ... may be a useful treatment for type 1 ... American Association,of Immunologists meeting in San Diego, California ...
... DEARBORN, Mich., April 7, 2008 Wayne State,University ... implanted a new device designed to combat congestive ... become a leading tool in,the arsenal to combat ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080407/DC18745 ), The April ...
Cached Medicine Technology:Rigel's R788 Shows Preclinical Activity in Type 1 Diabetes Model 2Rigel's R788 Shows Preclinical Activity in Type 1 Diabetes Model 3Wayne State University and Oakwood Partner in New Device to Combat Congestive Heart Failure 2Wayne State University and Oakwood Partner in New Device to Combat Congestive Heart Failure 3Wayne State University and Oakwood Partner in New Device to Combat Congestive Heart Failure 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: